Department of Medical Education, Chang Gung Memorial Hospital.
Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University.
Circ J. 2024 Feb 22;88(3):309-318. doi: 10.1253/circj.CJ-23-0146. Epub 2023 Aug 29.
In Taiwan, infective native aortic aneurysms (INAAs) are relatively common, so the aim of present study was to demonstrate the comparative outcomes of endovascular repair for thoracic and abdominal INAAs.
Patients with naïve thoracic or abdominal INAAs managed with endovascular repair between 2001 and 2018 were included in this multicenter retrospective cohort. The confounding factors were adjusted with propensity score (PS). Of the 39 thoracic and 43 abdominal INAA cases, 41 (50%) presented with aneurysmal rupture, most of which were at the infrarenal abdominal (n=35, 42.7%) or descending thoracic aorta (n=25, 30.5%). Salmonella spp. was the most frequently isolated pathogen. The overall in-hospital mortality rate was 18.3%. The risks of in-hospital death and death due to rupture were significantly lower with thoracic INAAs (12.8% vs. 23.3%; PS-adjusted odds ratio (OR) 0.24, 95% confidence interval (CI) 0.06-0.96; 0.1% vs. 9.3%; PS-adjusted OR 0.11, 95% CI 0.01-0.90). During a mean follow-up of 2.5 years, the risk of all-cause death was significantly higher with thoracic INAAs (35.3% vs. 15.2%; PS-adjusted HR 6.90, 95% CI 1.69-28.19). Chronic kidney disease (CKD) was associated with death.
Compared with thoracic INAAs, endovascular repair of abdominal INAAs was associated with a significantly higher in-hospital mortality rate. However, long-term outcomes were worse for thoracic INAAs, with CKD and infections being the most important predictor and cause of death, respectively.
在台湾,感染性原生主动脉瘤(INAAs)较为常见,因此本研究旨在比较胸腹部 INAA 行血管内修复的治疗效果。
本多中心回顾性队列研究纳入了 2001 年至 2018 年期间接受血管内修复治疗的胸腹部 INAA 初治患者。采用倾向性评分(PS)调整混杂因素。39 例胸腹部 INAA 患者中,41 例(50%)发生动脉瘤破裂,其中大部分位于腹主动脉下段(n=35,42.7%)或降主动脉(n=25,30.5%)。最常见的分离病原体为沙门氏菌属。总体院内死亡率为 18.3%。胸腹部 INAA 的院内死亡风险(12.8%比 23.3%;PS 校正比值比(OR)0.24,95%置信区间(CI)0.06-0.96)和因破裂导致的死亡风险(0.1%比 9.3%;PS 校正 OR 0.11,95%CI 0.01-0.90)显著更低。平均随访 2.5 年后,胸腹部 INAA 的全因死亡风险(35.3%比 15.2%;PS 校正 HR 6.90,95%CI 1.69-28.19)显著更高。慢性肾脏病(CKD)与死亡相关。
与胸腹部 INAA 相比,血管内修复腹主动脉 INAA 与院内死亡率显著增加相关。然而,胸腹部 INAA 的长期预后更差,CKD 和感染分别是最重要的死亡预测因素和死亡原因。